MIRA Accounts Payable vs Other Current Assets Analysis
| MIRA Stock | 1.15 0.10 8.00% |
MIRA Pharmaceuticals, financial indicator trend analysis is infinitely more than just investigating MIRA Pharmaceuticals, recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MIRA Pharmaceuticals, is a good investment. Please check the relationship between MIRA Pharmaceuticals, Accounts Payable and its Other Current Assets accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MIRA Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Accounts Payable vs Other Current Assets
Accounts Payable vs Other Current Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MIRA Pharmaceuticals, Accounts Payable account and Other Current Assets. At this time, the significance of the direction appears to have pay attention.
The correlation between MIRA Pharmaceuticals,'s Accounts Payable and Other Current Assets is -0.78. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Other Current Assets in the same time period over historical financial statements of MIRA Pharmaceuticals, Common, assuming nothing else is changed. The correlation between historical values of MIRA Pharmaceuticals,'s Accounts Payable and Other Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of MIRA Pharmaceuticals, Common are associated (or correlated) with its Other Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Assets has no effect on the direction of Accounts Payable i.e., MIRA Pharmaceuticals,'s Accounts Payable and Other Current Assets go up and down completely randomly.
Correlation Coefficient | -0.78 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Accounts Payable
An accounting item on the balance sheet that represents MIRA Pharmaceuticals, obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of MIRA Pharmaceuticals, are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Other Current Assets
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.Most indicators from MIRA Pharmaceuticals,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MIRA Pharmaceuticals, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MIRA Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. The current year's Selling General Administrative is expected to grow to about 6.8 M, whereas Issuance Of Capital Stock is forecasted to decline to about 6.1 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 24.4K | 10.3K | 3.5M | 3.6M | Depreciation And Amortization | 2.2K | 7.0K | 8.5M | 9.0M |
MIRA Pharmaceuticals, fundamental ratios Correlations
Click cells to compare fundamentals
MIRA Pharmaceuticals, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether MIRA Pharmaceuticals, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MIRA Pharmaceuticals,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mira Pharmaceuticals, Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mira Pharmaceuticals, Common Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MIRA Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MIRA Pharmaceuticals,. If investors know MIRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MIRA Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Return On Assets (1.78) | Return On Equity (7.49) |
The market value of MIRA Pharmaceuticals, is measured differently than its book value, which is the value of MIRA that is recorded on the company's balance sheet. Investors also form their own opinion of MIRA Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is MIRA Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MIRA Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect MIRA Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MIRA Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if MIRA Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MIRA Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.